International Diabetes Federation: a consensus on Type 2 diabetes prevention

被引:477
作者
Alberti, K. G. M. M. [1 ]
Zimmet, P. [1 ]
Shaw, J. [1 ]
机构
[1] St Marys Hosp, Dept Endocrinol & Metab Med, London W2 1NY, England
关键词
International Diabetes Federation; population; prevention; risk factors; Type; 2; diabetes;
D O I
10.1111/j.1464-5491.2007.02157.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Early intervention and avoidance or delay of progression to Type 2 diabetes is of enormous benefit to patients in terms of increasing life expectancy and quality of life, and potentially in economic terms for society and health-care payers. To address the growing impact of Type 2 diabetes the International Diabetes Federation (IDF) Taskforce on Prevention and Epidemiology convened a consensus workshop in 2006. The primary goal of the workshop and this document was the prevention of Type 2 diabetes in both the developed and developing world. A second aim was to reduce the risk of cardiovascular disease in people who are identified as being at a higher risk of Type 2 diabetes. The IDF plan for prevention of Type 2 diabetes is based on controlling modifiable risk factors and can be divided into two target groups: People at high risk of developing Type 2 diabetes The entire population. Conclusions In planning national measures for the prevention of Type 2 diabetes, both groups should be targeted simultaneously with lifestyle modification the primary goal through a stepwise approach. In addition, it is important that all activities are tailored to the specific local situation. Further information on the prevention of diabetes can be found on the IDF website: http://www.idf.org/prevention.
引用
收藏
页码:451 / 463
页数:13
相关论文
共 56 条
[41]   Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland, and the United Kingdom [J].
Palmer, AJ ;
Roze, S ;
Valentine, WJ ;
Spinas, GA ;
Shaw, JE ;
Zimmet, PZ .
CLINICAL THERAPEUTICS, 2004, 26 (02) :304-321
[42]   Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance - The Da Qing IGT and diabetes study [J].
Pan, XR ;
Li, GW ;
Hu, YH ;
Wang, JX ;
Yang, WY ;
An, ZX ;
Hu, ZX ;
Lin, J ;
Xiao, JZ ;
Cao, HB ;
Liu, PA ;
Jiang, XG ;
Jiang, YY ;
Wang, JP ;
Zheng, H ;
Zhang, H ;
Bennett, PH ;
Howard, BV .
DIABETES CARE, 1997, 20 (04) :537-544
[43]   The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) [J].
Ramachandran, A ;
Snehalatha, C ;
Mary, S ;
Mukesh, B ;
Bhaskar, AD ;
Vijay, V .
DIABETOLOGIA, 2006, 49 (02) :289-297
[44]   High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey [J].
Ramachandran, A ;
Snehalatha, C ;
Kapur, A ;
Vijay, V ;
Mohan, V ;
Das, AK ;
Rao, PV ;
Yajnik, CS ;
Kumar, KMP ;
Nair, JD .
DIABETOLOGIA, 2001, 44 (09) :1094-1101
[45]   Abdominal adiposity and coronary heart disease in women [J].
Rexrode, KM ;
Carey, VJ ;
Hennekens, CH ;
Walters, EE ;
Colditz, GA ;
Stampfer, MJ ;
Willett, WC ;
Manson, JAE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1843-1848
[46]  
SARISTO T, 2005, DIABETES VASC DIS RE, V2, P67
[47]   Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study [J].
Scheen, Andre J. ;
Finer, Nick ;
Hollander, Priscilla ;
Jensen, Michael D. ;
Van Gaal, Luc F. .
LANCET, 2006, 368 (9548) :1660-1672
[48]   How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level? [J].
Simmons, RK ;
Harding, AH ;
Jakes, RW ;
Welch, A ;
Wareham, NJ ;
Griffin, SJ .
DIABETOLOGIA, 2006, 49 (05) :905-911
[49]   Type 2 diabetes: principles of pathogenesis and therapy [J].
Stumvoll, M ;
Goldstein, BJ ;
van Haeften, TW .
LANCET, 2005, 365 (9467) :1333-1346
[50]   XENical in the prevention of diabetes in obese subjects (XENDOS) study [J].
Torgerson, JS ;
Hauptman, J ;
Boldrin, MN ;
Sjöström, L .
DIABETES CARE, 2004, 27 (01) :155-161